ZACHARY ANNEN: Open Payments
NPI 1427480318 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,028 in 9 payments from 3 companies in 2025. Trend: 2023 $230 · 2024 $269 · 2025 $3,028
Honoraria: $1,573Travel & lodging: $877Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 7 | $2,786 |
| Janssen Biotech, Inc. | 1 | $128 |
| Astellas Pharma US Inc | 1 | $115 |
Products named: JELMYTO, RYBREVANT, Padcev.
Industry payments across WA — which companies pay providers there.
